Literature DB >> 22706993

Inhibition of T-cell activation by PIK3IP1.

Marie C DeFrances1, Daniel R Debelius, Jing Cheng, Lawrence P Kane.   

Abstract

The PI-3 kinase (PI3K) pathway is critical for T-cell development and activation. Several negative regulators of this pathway have already been described and characterized: the lipid phosphatases SHIP, inositol polyphosphate-4-phosphatase, type II (INPP4B), and phosphatase and tensin homolog (PTEN), the latter of which are tumor suppressors. PIK3IP1 (PI3K interacting protein 1) is a recently described transmembrane protein that has the ability to bind the catalytic protein p110 and prevent its activation by the p85 family adaptor proteins. Thus far, nothing is known about the possible role of PIK3IP1 in the regulation of lymphocyte development or activation. Here, we show for the first time that PIK3IP1 is expressed in T cells. Ectopic expression of PIK3IP1 in Jurkat or D10 T-cell lines inhibited activation of an NFAT/AP-1 transcriptional reporter. Conversely, siRNA-mediated silencing of PIK3IP1 in the same cell lines modestly augmented Akt phosphorylation, T-cell activation, and production of IL-2. These results suggest that the novel PI3K regulator PIK3IP1 plays an inhibitory role in T-cell activation.
© 2012 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22706993      PMCID: PMC3654810          DOI: 10.1002/eji.201141653

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  15 in total

Review 1.  PI3K in lymphocyte development, differentiation and activation.

Authors:  Klaus Okkenhaug; Bart Vanhaesebroeck
Journal:  Nat Rev Immunol       Date:  2003-04       Impact factor: 53.106

Review 2.  Targeting the PI3K-Akt pathway in human cancer: rationale and promise.

Authors:  Ji Luo; Brendan D Manning; Lewis C Cantley
Journal:  Cancer Cell       Date:  2003-10       Impact factor: 31.743

3.  PI3K is negatively regulated by PIK3IP1, a novel p110 interacting protein.

Authors:  Zhenqi Zhu; Xin He; Carla Johnson; John Stoops; Amanda E Eaker; David S Stoffer; Aaron Bell; Reza Zarnegar; Marie C DeFrances
Journal:  Biochem Biophys Res Commun       Date:  2007-04-24       Impact factor: 3.575

4.  Induction of NF-kappaB by the Akt/PKB kinase.

Authors:  L P Kane; V S Shapiro; D Stokoe; A Weiss
Journal:  Curr Biol       Date:  1999-06-03       Impact factor: 10.834

Review 5.  Perturbations of the AKT signaling pathway in human cancer.

Authors:  Deborah A Altomare; Joseph R Testa
Journal:  Oncogene       Date:  2005-11-14       Impact factor: 9.867

6.  Deficiency of PTEN in Jurkat T cells causes constitutive localization of Itk to the plasma membrane and hyperresponsiveness to CD3 stimulation.

Authors:  X Shan; M J Czar; S C Bunnell; P Liu; Y Liu; P L Schwartzberg; R L Wange
Journal:  Mol Cell Biol       Date:  2000-09       Impact factor: 4.272

7.  Evidence that SHIP-1 contributes to phosphatidylinositol 3,4,5-trisphosphate metabolism in T lymphocytes and can regulate novel phosphoinositide 3-kinase effectors.

Authors:  Robin W Freeburn; Karen L Wright; Steven J Burgess; Emmanuelle Astoul; Doreen A Cantrell; Stephen G Ward
Journal:  J Immunol       Date:  2002-11-15       Impact factor: 5.422

8.  p21ras initiates Rac-1 but not phosphatidyl inositol 3 kinase/PKB, mediated signaling pathways in T lymphocytes.

Authors:  E Genot; K Reif; S Beach; I Kramer; D Cantrell
Journal:  Oncogene       Date:  1998-10-01       Impact factor: 9.867

9.  A proline-rich motif in the C terminus of Akt contributes to its localization in the immunological synapse.

Authors:  Lawrence P Kane; Marianne N Mollenauer; Arthur Weiss
Journal:  J Immunol       Date:  2004-05-01       Impact factor: 5.422

10.  Ligation of the T cell co-stimulatory receptor CD28 activates the serine-threonine protein kinase protein kinase B.

Authors:  R V Parry; K Reif; G Smith; D M Sansom; B A Hemmings; S G Ward
Journal:  Eur J Immunol       Date:  1997-10       Impact factor: 5.532

View more
  17 in total

1.  Distinct Regulation of Th17 and Th1 Cell Differentiation by Glutaminase-Dependent Metabolism.

Authors:  Marc O Johnson; Melissa M Wolf; Matthew Z Madden; Gabriela Andrejeva; Ayaka Sugiura; Diana C Contreras; Damian Maseda; Maria V Liberti; Katelyn Paz; Rigel J Kishton; Matthew E Johnson; Aguirre A de Cubas; Pingsheng Wu; Gongbo Li; Yongliang Zhang; Dawn C Newcomb; Andrew D Wells; Nicholas P Restifo; W Kimryn Rathmell; Jason W Locasale; Marco L Davila; Bruce R Blazar; Jeffrey C Rathmell
Journal:  Cell       Date:  2018-11-01       Impact factor: 41.582

2.  A cardiac myocyte-restricted Lin28/let-7 regulatory axis promotes hypoxia-mediated apoptosis by inducing the AKT signaling suppressor PIK3IP1.

Authors:  Shaurya Joshi; Jianqin Wei; Nanette H Bishopric
Journal:  Biochim Biophys Acta       Date:  2015-12-02

3.  PIK3IP1 Promotes Extrafollicular Class Switching in T-Dependent Immune Responses.

Authors:  Kristina Ottens; Jalyn Schneider; Lawrence P Kane; Anne B Satterthwaite
Journal:  J Immunol       Date:  2020-09-04       Impact factor: 5.422

4.  Expression of PIK3IP1 in the murine uterus during early pregnancy.

Authors:  Hanna E Teasley; Hye Jin Chang; Tae Hoon Kim; Bon Jeong Ku; Jae-Wook Jeong
Journal:  Biochem Biophys Res Commun       Date:  2017-12-28       Impact factor: 3.575

5.  Control of CD4+ T Cell Differentiation and Function by PI3K Isoforms.

Authors:  Benjamin Cameron; Syed Aymaan Zaheer; Margarita Dominguez-Villar
Journal:  Curr Top Microbiol Immunol       Date:  2022       Impact factor: 4.737

6.  Whole-genome sequence analysis reveals selection signatures for important economic traits in Xiang pigs.

Authors:  Xiying Wang; Xueqin Ran; Xi Niu; Shihui Huang; Sheng Li; Jiafu Wang
Journal:  Sci Rep       Date:  2022-07-12       Impact factor: 4.996

7.  Cutting Edge: Foxp1 Controls Naive CD8+ T Cell Quiescence by Simultaneously Repressing Key Pathways in Cellular Metabolism and Cell Cycle Progression.

Authors:  Hairong Wei; Jianlin Geng; Bi Shi; Zhenghui Liu; Yin-Hu Wang; Anna C Stevens; Stephanie L Sprout; Min Yao; Haikun Wang; Hui Hu
Journal:  J Immunol       Date:  2016-03-21       Impact factor: 5.422

8.  Pik3ip1 modulates cardiac hypertrophy by inhibiting PI3K pathway.

Authors:  Hong Ki Song; Jiyeon Kim; Jong Sub Lee; Kyoung Jin Nho; Hae Chang Jeong; Jihwa Kim; Youngkeun Ahn; Woo Jin Park; Do Han Kim
Journal:  PLoS One       Date:  2015-03-31       Impact factor: 3.240

9.  Induction of prolonged early G1 arrest by CDK4/CDK6 inhibition reprograms lymphoma cells for durable PI3Kδ inhibition through PIK3IP1.

Authors:  David Chiron; Peter Martin; Maurizio Di Liberto; Xiangao Huang; Scott Ely; Brian J Lannutti; John P Leonard; Christopher E Mason; Selina Chen-Kiang
Journal:  Cell Cycle       Date:  2013-05-15       Impact factor: 4.534

10.  PI3Kγ kinase activity is required for optimal T-cell activation and differentiation.

Authors:  Nadia Ladygina; Sridevi Gottipati; Karen Ngo; Glenda Castro; Jing-Ying Ma; Homayon Banie; Tadimeti S Rao; Wai-Ping Fung-Leung
Journal:  Eur J Immunol       Date:  2013-10-09       Impact factor: 5.532

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.